Teleflex reported a 3.1% decrease in third quarter revenue to $628.3 million compared to the prior year. GAAP EPS decreased by 49.3% to $2.46, while adjusted diluted EPS decreased by 6.7% to $2.77. The company noted a negative impact of approximately $78 million due to COVID-19.
Third quarter revenues were $628.3 million, a 3.1% decrease year-over-year, or 4.1% on a constant currency basis.
GAAP diluted EPS from continuing operations was $2.46, compared to $4.85 in the prior year period.
Adjusted diluted EPS from continuing operations was $2.77, a 6.7% decrease year-over-year.
The company estimates COVID-19 had a net negative impact to revenue of approximately $78 million, or 12%.
Teleflex anticipates continued sequential improvement during the fourth quarter of 2020 compared to the third quarter results. The acquisition of Z-Medica is expected to be accretive to adjusted earnings per share in 2021.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance